Period of time： 2013年3期
Publisher： Informa Healthcare
Founded in： 2005
Total resources： 4
ISSN： 1744-666X
Subject： R3 Basic Medical
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Review of Clinical Immunology,volume 9,issue 3
Menu
The benefits and risks of alemtuzumab in multiple sclerosis
By Ontaneda Daniel,Cohen Jeffrey A in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.
Access to resources
Recommend
Infections during treatment with biological agents and possible treatment in clinical practice
By Atzeni Fabiola,Benucci Maurizio,Sarzi-Puttini Piercarlo in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.Fueling autoimmunity: type I interferon in autoimmune diseases
By Di Domizio Jeremy,Cao Wei in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.Immunopathogenesis of allergic disorders: current concepts
By Kumar Yashwant,Bhatia Alka in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.Allergy to ortho-phthalaldehyde in the healthcare setting: advice for clinicians
By Pala Gianni,Moscato Gianna in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults
By Ponticelli Claudio,Graziani Giorgio in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.Leptospirosis: current situation and trends of specific laboratory tests
By Schreier Stefan,Doungchawee Galayanee,Chadsuthi Sudarat,Triampo Darapond,Triampo Wannapong in (2013)
Expert Review of Clinical Immunology,volume 9,issue 3 , Vol. 9, Iss. 3, 2013-03 , pp.
Previous
Next